CSL Limited (CSL.AX) is in Healthcare, Biotechnology, based in Australia, listed on ASX. Market cap 88.22B AUD. 52-week range 90.00 to 222.47 AUD. Trailing P/E 15.4. Data as of 2026-10-09.
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. The CSL Seqirus segment manufactures, markets, and ...